The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

Timothy M.E. Davis; Sharon Maxwell; Cathy Chan; Helen I. Keen; Wendy A. Davis

doi:10.1111/dom.15295

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

Timothy M.E. Davis, Sharon Maxwell, Cathy Chan, Helen I. Keen, Wendy A. Davis

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	385-388
Number of pages	4
Journal	Diabetes, Obesity and Metabolism
Volume	26
Issue number	1
Early online date	19 Sept 2023
DOIs	https://doi.org/10.1111/dom.15295
Publication status	Published - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dom.15295Licence: CC BY-NC-ND

Cite this

@article{ff1d3d1d970645419f50257811b0230e,

title = "The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes",

keywords = "empagliflozin, lipid-lowering therapy, pharmacodynamics, randomized trial",

author = "Davis, {Timothy M.E.} and Sharon Maxwell and Cathy Chan and Keen, {Helen I.} and Davis, {Wendy A.}",

year = "2024",

month = jan,

doi = "10.1111/dom.15295",

language = "English",

volume = "26",

pages = "385--388",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

AU - Davis, Timothy M.E.

AU - Maxwell, Sharon

AU - Chan, Cathy

AU - Keen, Helen I.

AU - Davis, Wendy A.

PY - 2024/1

Y1 - 2024/1

KW - empagliflozin

KW - lipid-lowering therapy

KW - pharmacodynamics

KW - randomized trial

UR - http://www.scopus.com/inward/record.url?scp=85171420797&partnerID=8YFLogxK

U2 - 10.1111/dom.15295

DO - 10.1111/dom.15295

M3 - Article

C2 - 37724708

AN - SCOPUS:85171420797

SN - 1462-8902

VL - 26

SP - 385

EP - 388

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 1

ER -

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

UN SDGs

Access to Document

Other files and links

Cite this